The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Open accessAbstract
SUMMARY FXR agonists are used to treat non-alcoholic fatty liver disease (NAFLD), in part because they reduce hepatic lipids. Here, we show that FXR activation with the FXR agonist GSK2324 controls hepatic lipids via reduced absorption and selective decreases in fatty acid synthesis. Using comprehensive lipidomic analyses, we show that FXR activation in mice or humans specifically reduces hepatic levels of mono- and polyunsaturated fatty acids (MUFA and PUFA). Decreases in MUFA are due to FXR-dependent repression of Scd1, Dgat2, and Lpin1 expression, which is independent of SHP and SREBP1c. FXR-dependent decreases in PUFAs are mediated by decreases in lipid absorption. Replenishing bile acids in the diet prevented decreased lipid absorption in GSK2324-treated mice, suggesting that FXR reduces absorption via decreased bile acids. We used tissue-specific FXR KO mice to show that hepatic FXR controls lipogenic genes, whereas intestinal FXR controls lipid absorption. Together, our studies establish two distinct pathways by which FXR regulates hepatic lipids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Self-citationHuman Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
Pleiotropic Roles of Bile Acids in Metabolism
de Aguiar Vallim, T. Q., Tarling, E. J., & Edwards, P. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.013 · Cited by 1,209
Self-citationTriglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170012 · Cited by 1,016
ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION
Burr, G. O., & Burr, M. M. (1930) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78929-5 · Cited by 994
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Birkenfeld, A. L., & Shulman, G. I. (2014) · Hepatology · doi:10.1002/hep.26672 · Cited by 738
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Intestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Nutrient-sensing nuclear receptors coordinate autophagy
Lee, J. M., Wagner, M., Xiao, R., Kim, K. H., Feng, D., Lazar, M. A., & Moore, D. D. (2014) · Nature · doi:10.1038/nature13961 · Cited by 518
Regulation of intestinal lipid metabolism: current concepts and relevance to disease
Ko, C.-W., Qu, J., Black, D. D., & Tso, P. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0250-7 · Cited by 510
Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis
Takeuchi, K., & Reue, K. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90958.2008 · Cited by 463
Hofmann, A. F., & Borgström, B. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104909 · Cited by 443
Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism
Flowers, M. T., & Ntambi, J. M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f9b54d · Cited by 438
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., & Patterson, A. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.057 · Cited by 372
Huynh, K., Barlow, C. K., Jayawardana, K. S., Weir, J. M., Mellett, N. A., Cinel, M., Magliano, D. J., Shaw, J. E., Drew, B. G., & Meikle, P. J. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.10.008 · Cited by 364
Self-citationBile acids in glucose metabolism and insulin signalling — mechanisms and research needs
Ahmad, T. R., & Haeusler, R. A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0266-7 · Cited by 337
The enterohepatic circulation of bile acids in mammals: form and functions
Hofmann, A. (2009) · Frontiers in Bioscience · doi:10.2741/3399 · Cited by 322
Kleiner, D. E., & Makhlouf, H. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.011 · Cited by 303
Cholic acid mediates negative feedback regulation of bile acid synthesis in mice
Li-Hawkins, J., Gåfvels, M., Olin, M., Lund, E. G., Andersson, U., Schuster, G., Björkhem, I., Russell, D. W., & Eggertsen, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216309 · Cited by 227
Discovery of essential fatty acids
Spector, A. A., & Kim, H.-Y. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r055095 · Cited by 218
Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine†
Thomas, A. M., Hart, S. N., Kong, B., Fang, J., Zhong, X., & Guo, G. L. (2010) · Hepatology · doi:10.1002/hep.23450 · Cited by 205
de Aguiar Vallim, T. Q., Tarling, E. J., Kim, T., Civelek, M., Baldán, Á., Esau, C., & Edwards, P. A. (2013) · Circulation Research · doi:10.1161/circresaha.112.300648 · Cited by 166
Self-citationHuang, J., Iqbal, J., Saha, P. K., Liu, J., Chan, L., Hussain, M. M., Moore, D. D., & Wang, L. (2007) · Hepatology · doi:10.1002/hep.21632 · Cited by 151
Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
Zhang, Y., Ge, X., Heemstra, L. A., Chen, W., Xu, J., Smith, J. L., Ma, H., Kasim, N., Edwards, P. A., & Novak, C. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1157 · Cited by 134
Self-citationWang, B., Rong, X., Duerr, M. A., Hermanson, D. J., Hedde, P. N., Wong, J. S., Vallim, T. Q. D. A., Cravatt, B. F., Gratton, E., Ford, D. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.001 · Cited by 132
An integrative systems genetic analysis of mammalian lipid metabolism
Parker, B. L., Calkin, A. C., Seldin, M. M., Keating, M. F., Tarling, E. J., Yang, P., Moody, S. C., Liu, Y., Zerenturk, E. J., Needham, E. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0984-y · Cited by 131
Self-citationMAFG Is a Transcriptional Repressor of Bile Acid Synthesis and Metabolism
Vallim, T. Q. D. A., Tarling, E. J., Ahn, H., Hagey, L. R., Romanoski, C. E., Lee, R. G., Graham, M. J., Motohashi, H., Yamamoto, M. P., & Edwards, P. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.007 · Cited by 119
Self-citationA novel, noninvasive method for the measurement of intestinal fat absorption
Jandacek, R. J., Heubi, J. E., & Tso, P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.007 · Cited by 117
Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
Zhang, Y., Yin, L., Anderson, J., Ma, H., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083899 · Cited by 112
Self-citationMoser, G., & McLachlan, M. S. (1999) · Chemosphere · doi:10.1016/s0045-6535(99)00219-2 · Cited by 99
Rizzolo, D., Buckley, K., Kong, B., Zhan, L., Shen, J., Stofan, M., Brinker, A., Goedken, M., Buckley, B., & Guo, G. L. (2019) · Hepatology · doi:10.1002/hep.30612 · Cited by 83
Matsukuma, K. E., Bennett, M. K., Huang, J., Wang, L., Gil, G., & Osborne, T. F. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600342-jlr200 · Cited by 75
Schumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 67
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Al-Dury, S., Wahlstrom, A. M., Panzitt, K., Thorell, A., Ståhlman, M., Trauner, M., Fickert, P., Bäckhed, F., Fändriks, L., Wagner, M., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.011 · Cited by 66
Self-citationBass, J. Y., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Madauss, K. P., Marr, H. B., McFadyen, R. B., Miller, A. B., Mills, W. Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.089 · Cited by 62
Profiling of mouse macrophage lipidome using direct infusion shotgun mass spectrometry
Hsieh, W.-Y., Williams, K. J., Su, B., et al. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100235 · Cited by 61
Self-citationRNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism
Tarling, E. J., Clifford, B. L., Cheng, J., Morand, P., Cheng, A., Lester, E., Sallam, T., Turner, M., & Vallim, T. Q. D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94029 · Cited by 59
Self-citationZhang, P., Csaki, L. S., Ronquillo, E., Baufeld, L., Lin, J. Y., Gutierrez, A., Dwyer, J. R., Brindley, D. N., Fong, L. G., Tontonoz, P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122595 · Cited by 54
Akinrotimi, O., Riessen, R., VanDuyne, P., Park, J. E., Lee, Y., Wong, L., Zavacki, A. M., Schoonjans, K., & Anakk, S. (2017) · Hepatology · doi:10.1002/hep.29305 · Cited by 50
Ding, L., Zhang, E., Yang, Q., Jin, L., Sousa, K. M., Dong, B., Wang, Y., Tu, J., Ma, X., Tian, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019388118 · Cited by 50
β-Muricholic acid; potentiometric and cholesterol-dissolving properties
Montet, J. C., Parquet, M., SACQUET, E., Montet, A. M., Infante, R., & Amic, J. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90002-6 · Cited by 47
Bonde, Y., Eggertsen, G., & Rudling, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147772 · Cited by 47
Obeticholic acid for the treatment of nonalcoholic steatohepatitis
Shah, R. A., & Kowdley, K. V. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1748498 · Cited by 47
Loss of small heterodimer partner expression in the liver protects against dyslipidemia
Hartman, H. B., Lai, K., & Evans, M. J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800323-jlr200 · Cited by 42
Zhang, H., Léveillé, M., Courty, É., Güneş, A., Nguyen, B., & Estall, J. L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2020 · Cited by 36
Jones, R., Repa, J. J., Russell, D. W., Dietschy, J. M., & Turley, S. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00111.2012 · Cited by 21
Cited by
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 497
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242
“151 Moreover, other FXR agonists have been used in randomized control trials as ciclo-flexor (GS-9674) in patients with MASH, decreasing hepatic steatosis, the transaminases in serum and the circulating BAs.”
MethodRatziu, V., Harrison, S. A., Loustaud-Ratti, V., Bureau, C., Lawitz, E., Abdelmalek, M., Alkhouri, N., Francque, S., Girma, H., Darteil, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.023 · Cited by 101
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“…highly expressed in the liver and intestine, can regulate the expression of genes involved in the pathogenesis of MASH by regulating cholesterol and bile acid homeostasis, hepatic gluconeogenesis, lipogenesis, intestinal barrier integrity, bacterial translocation and the gut microbiota [192, 193].”
Metadata
- Authors
- Clifford, B. L., Sedgeman, L. R., Williams, K. J., Morand, P., Cheng, A., Jarrett, K. E., Chan, A. P., Brearley-Sholto, M. C., Wahlström, A., Ashby, J. W., Barshop, W., Wohlschlegel, J., Calkin, A. C., Liu, Y., Thorell, A., Meikle, P. J., Drew, B. G., Mack, J. J., Marschall, H.-U., Tarling, E. J., Edwards, P. A., & de Aguiar Vallim, T. Q.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 33
- Issue
- 8
- Pages
- 1671-1684.e4
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3181456162
- Cited by
- 487
- References
- 56
- FWCI
- 39.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.